The long-term outcomes of human West Nile virus infection

Clinical Infectious Diseases

Volumn 44, Issue 12, 2007, Pages 1617-1624

  Sejvar, James J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; DISEASE ASSOCIATION; FUNCTIONAL ASSESSMENT; HUMAN; LIMB WEAKNESS; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARKINSONISM; POLIOMYELITIS; POSTPOLIOMYELITIS SYNDROME; PRIORITY JOURNAL; REVIEW; SOMATIZATION; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ACUTE DISEASE; COGNITION DISORDERS; ENCEPHALITIS, VIRAL; HUMANS; MENINGITIS, VIRAL; POLIOMYELITIS; PROGNOSIS; RECOVERY OF FUNCTION; SURVIVORS; TIME FACTORS; UNITED STATES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 34249914817     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518281     Document Type: Review

References (35)

1. Centers for Disease Control and Prevention. West Nile virus activity - United States, January 1-November 7, 2006. MMWR Morb Mortal Wkly Rep 2006; 55:1204-5.
2. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2:519-29.
3. Chowers MY, Lang R, Nassar F, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis 2001; 7:675-8.
4. Campbell GL, Ceianu CS, Savage HM. Epidemic West Nile encephalitis in Romania: waiting for history to repeat itself. Ann N Y Acad Sci 2001; 951:94-101.
5. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290:511-5.
6. Berner YN, Lang R, Chowers MY. Outcome of West Nile fever in older adults. J Am Geriatr Soc 2002; 50:1844-6.
7. Bode AV, Sejvar JJ, Rape WJ, Campbell GL, Marfin AA. West Nile virus disease: a descriptive study of 228 patients hospitalized in a 4-county region of Colorado in 2003. Clin Infect Dis 2006; 42:1234-40.
8. Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis 2004; 38:289-92.
9. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 2004; 141:360-5.
10. Carson PJ, Konweko P, Wold KS, et al. Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 2006; 43:723-30.
11. Haaland KY, Sadek J, Pergam S, et al. Mental status after West Nile virus infection. Emerg Infect Dis 2006; 12:1260-2.
12. Klee AL, Maidin B, Edwin B, et al. Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 2004; 10:1405-11.
13. Patnaik JL, Harmon H, Vogt RL. Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 2006; 12:1129-31.
14. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in south-central Ontario. CMAJ 2003; 168:1399-405.
15. Ou AC, Ratard RC. One-year sequelae in patients with West Nile virus encephalitis and meningitis in Louisiana. J La State Med Soc 2005; 157:42-6.
16. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 2005; 11:1021-7.
17. Green MS. Long-term death rates. West Nile virus epidemic, Israel, 2000. Emerg Infect Dis 2005; 11:1754-7.
18. Robinson RL, Shahida S, Madan N, Rao S, Khardori N. Transient parkinsonism in West Nile virus encephalitis. Am J Med 2003; 115:252-3.
19. Burton JM, Kern RZ, Halliday W, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004; 31:185-93.
20. Sejvar JI, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006; 12:514-6.
21. Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003; 28:302-8.
22. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003; 53:703-10.
23. Cao NJ, Ranganathan C, Kupsky WJ, Li J. Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 2005; 236:73-80.
24. Guyton A. Reaction of the body to poliomyelitis and the recovery process. Arch Int Med 1949; 83:27.
25. Marciniak C, Sorosky S, Hynes C. Acute flaccid paralysis associated with West Nile virus: motor and functional improvement in 4 patients. Arch Phys Med Rehabil 2004; 85:1933-8.
26. Miller NH, Miller DJ, Goldberg JL. Physical therapist examination, evaluation, and intervention for a patient with West Nile virus paralysis. Phys Ther 2006; 86:843-56.
27. Gottfried K, Quinn R, Jones T. Clinical description and follow-up investigation of human West Nile virus cases. South Med J 2005; 98:603-6.
28. Kuno G. Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts. Rev Med Virol 2001; 11:165-90.
29. Rail D, Scholtz C, Swash M. Post-encephalitic parkinsonism: current experience. J Neurol Neurosurg Psychiatry 1981; 44:670-6.
30. Mitsuyama Y, Fukunaga H, Takayama S. Parkinson's disease of post-encephalitic type following general paresis - an autopsied case. Folia Psychiatr Neurol Jpn 1983; 37:85-93.
31. Savant CS, Singhal BS, Jankovic J, Khan M, Virani A. Substantia nigra lesions in viral encephalitis. Mov Disord 2003; 18:213-6.
32. Guarner J, Shieh WJ, Hunter S, et al. Clinicopathologic study and laboratory diagnosis of 23 cases with West Nile virus encephalomyelitis. Hum Pathol 2004; 35:983-90.
33. Ogata A, Humaue N, Terado M, Minami M, Nagashima K, Tashiro K. Isatin, an endogenous MAO inhibitor, improves bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by Japanese encephalitis virus. J Neurol Sci 2003; 206:79-83.
34. Naoi M, Maruyama W. Cell death of dopamine neurons in aging and Parkinson's disease. Mech Ageing Dev 1999; 111:175-88.
35. Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle Nerve 2005; 31:6-19.